Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Operating Leases (2019 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Operating Leases for 7 consecutive years, with $3.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Operating Leases rose 1401.62% to $3.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $3.7 million, a 1401.62% increase, with the full-year FY2024 number at $166000.0, down 78.13% from a year prior.
  • Operating Leases was $3.7 million for Q3 2025 at Xtant Medical Holdings, up from $2.0 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $3.7 million in Q3 2025 to a low of $121000.0 in Q1 2025.
  • A 5-year average of $1.0 million and a median of $916000.0 in 2023 define the central range for Operating Leases.
  • Biggest YoY gain for Operating Leases was 1401.62% in 2025; the steepest drop was 81.21% in 2025.
  • Xtant Medical Holdings' Operating Leases stood at $842000.0 in 2021, then grew by 15.44% to $972000.0 in 2022, then dropped by 21.91% to $759000.0 in 2023, then crashed by 78.13% to $166000.0 in 2024, then skyrocketed by 2134.34% to $3.7 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Operating Leases are $3.7 million (Q3 2025), $2.0 million (Q2 2025), and $121000.0 (Q1 2025).